Company Analysis

ADC Therapeutics SA (ADCT)

NYSE: ADCT · Pharmaceutical Preparations · Epalinges, CH · filing with the SEC since 2019
Grade5.3
◀ Past 5.5● Present 4.8▶ Future 6.0
2 est.

Filings

348 filings since 2017 beside 93 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 40 days after the quarter ended. The proxy statement was last filed Apr 20, 2026.

Filings a yearinsider forms included
1654485945946857
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Jul 2, 2026.SEC letters: 7 in the last 36 months, the newest Mar 12, 2026.
Insider forms 93

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 S-3 Shelf registration
Nov 9, 2026 10-Q Quarterly report Sep 30, 2026
Nov 9, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 4, 2026 8-K items 2.02, 7.01, 8.01, 9.01 Results released; Investor disclosure (Regulation FD); Other event · Current report
Nov 3, 2026 S-4 Merger or exchange registration
Oct 29, 2026 SCHEDULE 13G Large holder notice
Oct 13, 2026 8-K items 1.01, 2.02, 3.02, 9.01 Major agreement signed; Results released; Shares sold without registration · Current report Oct 7, 2026
Aug 14, 2026 SCHEDULE 13G Large holder notice
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 S-8 Employee stock plan registration
Aug 13, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jul 27, 2026 SCHEDULE 13G Large holder notice
Jul 2, 2026 8-K item 5.02 Officer or director change · Current report Jun 30, 2026
Jun 24, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Jun 3, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Jun 2, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Jun 1, 2026
May 4, 2026 10-Q Quarterly report Mar 31, 2026
May 4, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 24, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 20, 2026 DEF 14A Proxy statement Jun 1, 2026
Apr 20, 2026 DEFA14A Extra proxy material
Apr 15, 2026 424B3 Shelf offering
Apr 10, 2026 PRE 14A Preliminary proxy statement Jun 1, 2026
Apr 6, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 16, 2026 EFFECT Registration effective
Mar 16, 2026 424B3 Shelf offering
Mar 12, 2026 CORRESP Reply to the SEC
Mar 12, 2026 UPLOAD SEC comment letter
Mar 10, 2026 ARS Annual report to shareholders Dec 31, 2025
Mar 10, 2026 10-K Annual report Dec 31, 2025
Mar 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Mar 10, 2026 S-3 Shelf registration
Feb 23, 2026 8-K items 1.01, 3.02, 9.01 Major agreement signed; Shares sold without registration · Current report Feb 18, 2026
Feb 17, 2026 SCHEDULE 13G Large holder notice
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 13, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 12, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jan 8, 2026 8-K items 2.02, 7.01 Results released; Investor disclosure (Regulation FD) · Current report
40 of 348 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ADCT · research, not advice